Regenxbio RGNX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Product | ||||||
| Nippon Shinyaku Services | $1.01M-27.6% | $1.4M-76.5% | $5.93M+118% | $2.72M+53.3% | $1.77M— | |
| Other Service Revenue | $292K-83.7% | $1.79M+815% | $196K+12.6% | $174K-7.9% | $189K-55.6% | |
| Total Service Revenue | $1.3M-59.1% | $3.19M-48.0% | $6.13M+112% | $2.89M+47.4% | $1.96M+361% | |
| Zolgensma And Itvisma Royalties | $5.05M— | —— | —— | —— | $16.99M-16.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Regenxbio break its business down?
- Regenxbio (RGNX) reports revenue (gross) by product across 4 parts — Nippon Shinyaku Services, Other Service Revenue, Total Service Revenue and Zolgensma And Itvisma Royalties. Each is extracted from the segment footnotes and tracked over time.
- Where does Regenxbio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Regenxbio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
